Publication | Closed Access

Differences between in Vivo and in Vitro Sensitivity to Imatinib of Bcr/Abl+ Cells Obtained from Leukemic Patients

Hematological MalignancyTumor BiologyLeukemic PatientsMedicineMixed-phenotype Acute LeukemiaImmunologyHematologyBcr/abl+ CellsVitro SensitivityAdult T-cell Leukemia-lymphomaOncologyCell BiologyCancer ResearchMyeloid Neoplasia